Efficacy of repeated intravenous infusions of an anti–tumor necrosis factor α monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: Results of an open-label prospective study
Valeria Gerloni, Irene Pontikaki, Maurizio Gattinara, Francesca Desiati, Elide Lupi, Alfredomaria Lurati, Alessandra Salmaso, Flavio FantiniVolume:
52
Year:
2005
Language:
english
Pages:
6
DOI:
10.1002/art.20793
File:
PDF, 85 KB
english, 2005